Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107604905 | 10760490 | 5 | F | 20140211 | 20160706 | 20150204 | 20160712 | EXP | CA-ROCHE-1532353 | ROCHE | 62.79 | YR | F | Y | 0.00000 | 20160712 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107604905 | 10760490 | 1 | PS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0041,S0001E,S0002F | 103976 | 150 | MG | |||||||
| 107604905 | 10760490 | 2 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0041,S0001E,S0002F | 103976 | |||||||||
| 107604905 | 10760490 | 3 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0041,S0001E,S0002F | 103976 | |||||||||
| 107604905 | 10760490 | 4 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0041,S0001E,S0002F | 103976 | |||||||||
| 107604905 | 10760490 | 5 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0041,S0001E,S0002F | 103976 | |||||||||
| 107604905 | 10760490 | 6 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0041,S0001E,S0002F | 103976 | |||||||||
| 107604905 | 10760490 | 7 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0041,S0001E,S0002F | 103976 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 107604905 | 10760490 | 1 | Asthma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 107604905 | 10760490 | OT |
| 107604905 | 10760490 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 107604905 | 10760490 | Appendicitis | |
| 107604905 | 10760490 | Blood pressure systolic increased | |
| 107604905 | 10760490 | Body temperature decreased | |
| 107604905 | 10760490 | Forced expiratory volume decreased | |
| 107604905 | 10760490 | Forced vital capacity decreased | |
| 107604905 | 10760490 | Obstructive airways disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 107604905 | 10760490 | 1 | 20130730 | 0 | ||
| 107604905 | 10760490 | 2 | 20140211 | 0 | ||
| 107604905 | 10760490 | 3 | 20150217 | 0 | ||
| 107604905 | 10760490 | 4 | 20150409 | 0 | ||
| 107604905 | 10760490 | 5 | 20160511 | 0 | ||
| 107604905 | 10760490 | 6 | 20160608 | 0 | ||
| 107604905 | 10760490 | 7 | 20160706 | 0 |